GSA CAPITAL PARTNERS LLP - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$435,000
-31.7%
1,887,989
+6.0%
0.06%
-27.5%
Q4 2021$637,000
+105.5%
1,781,617
+245.1%
0.08%
+150.0%
Q3 2021$310,000
-58.7%
516,218
-23.7%
0.03%
-62.4%
Q2 2021$751,000
+35.6%
676,761
+56.5%
0.08%
-7.6%
Q1 2021$554,000
-28.1%
432,503
-62.1%
0.09%
-27.0%
Q4 2020$770,000
+1066.7%
1,141,049
+1344.3%
0.13%
+1045.5%
Q3 2020$66,000
+340.0%
79,001
+226.8%
0.01%
+37.5%
Q2 2020$15,00024,1770.01%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders